Underinsured Motorist Claim and Pharmacy Lien: A Case Study

James Wong — Founder & Pharmacist, LienScripts | February 11, 2026 | 9 min read

When the at-fault driver carried only $15,000 in liability coverage, the injured patient faced 16 months of medication needs and an adversarial UIM claim. A pharmacy lien bridged the entire treatment period — from the initial collision through the final underinsured motorist settlement.

Case Background

Note: This is a fictionalized case study based on composite facts. Names and identifying details are not real. The clinical details represent typical medication patterns for this injury type.

Kevin, 34, was rear-ended at a freeway on-ramp by a driver who had failed to match speed with merging traffic. The collision was forceful enough to deploy Kevin's headrest restraint and push his vehicle forward into the car ahead of him, creating a secondary impact. He was evaluated at an urgent care center the same day, where he reported acute cervical and lumbar pain. Imaging ordered at a follow-up visit ten days later revealed a herniated disc at L4-L5 with mild nerve root impingement.

Kevin's attorney retained a pain management specialist who initiated a structured medication protocol. Kevin was also referred for physical therapy and imaging-guided injections, with the expectation that his recovery would be measured in months rather than weeks.

The Insurance Coverage Gap

The at-fault driver — referred to here as the other motorist — carried California's minimum liability limits at the time: $15,000 per person for bodily injury. That policy limit was clearly inadequate to cover the scope of Kevin's injuries and anticipated treatment costs. The at-fault carrier tendered the full $15,000 within sixty days of the accident, acknowledging liability but exhausting their coverage entirely in one payment.

Kevin held his own auto policy with $100,000 in underinsured motorist (UIM) coverage — a meaningful safety net, but one that would require its own claim, its own investigation, and potentially its own litigation.

Kevin had no health insurance. He worked as a freelance contractor, and his income had dropped significantly since the accident. Retail pharmacy costs for a herniated disc patient on a structured medication protocol can run to several hundred dollars monthly, and Kevin had no way to sustain that expense across a case that his attorney estimated would take twelve to eighteen months to resolve.

[!KEY] Underinsured motorist claims are not quick. After the at-fault limits exhaust, the patient's own UIM carrier conducts its own independent investigation — which typically means months of additional waiting before any further funds are available. Pharmacy lien bridges that entire gap.

Pharmacy Lien Activated at Intake

Kevin's attorney referred him to LienScripts at the time of intake, before the at-fault limits were even tendered. The referral was made proactively because the attorney recognized from the outset that the coverage situation would create a prolonged medication-funding gap.

Kevin's initial prescriptions — cyclobenzaprine 5 mg, meloxicam 15 mg, and a diclofenac sodium topical gel for lumbar application — were dispensed on lien without any up-front payment. As his treatment progressed and his physician adjusted the protocol, subsequent medications were added: gabapentin 300 mg three times daily at month two, a compounded ketamine/lidocaine transdermal cream at month five for refractory lumbar pain, and ondansetron for medication-induced nausea.

Every prescription, every refill, every clinical change was recorded in a dated pharmacy record. By month six, Kevin's pharmacy lien had generated a comprehensive medication history that documented not just what he was taking, but how his treatment had evolved as the clinical picture changed.

The UIM Claim: Adversarial by Design

Once the at-fault limits were tendered and exhausted, Kevin's UIM carrier opened its own claim. Despite being Kevin's own insurer — one he had been paying premiums to for years — the UIM carrier conducted itself in a manner consistent with defending a third-party claim. They retained an independent medical examiner who questioned the necessity of several of Kevin's medications. They requested voluminous records. Their adjuster argued that portions of Kevin's treatment were related to a pre-existing lumbar condition he had mentioned during his recorded statement.

This type of adversarial dynamic is common in UIM claims. Insurers have a financial incentive to limit their exposure even when their own policyholder is the claimant. The investigation stretched for seven months before the UIM carrier made an initial settlement offer.

[!KEY] A patient's own UIM carrier is not a neutral party. They investigate, dispute, and negotiate in the same way a third-party carrier would. During that period, a pharmacy lien ensures the patient does not have to choose between continued treatment and financial survival.

Sixteen Months on Lien

By the time the UIM claim reached settlement, Kevin had been on pharmacy lien for sixteen months. His medication protocol had evolved three times as his pain management physician adjusted the regimen in response to clinical findings. The gabapentin dosage had been titrated upward, the compounded cream formulation had been modified twice, and a trial of low-dose naltrexone had been initiated at month ten as an adjunct therapy.

Kevin's pharmacy lien record across sixteen months told a precise story: a patient with an acute herniated disc who required sustained, physician-directed medication management; whose regimen changed in clinically coherent ways as his condition evolved; and whose medication adherence was continuous with no gaps suggestive of self-managed or minor injury.

When the UIM carrier's IME physician argued that Kevin's medications were excessive for his degree of injury, Kevin's attorney was able to respond with a month-by-month prescription record corroborated by corresponding clinical notes from the treating physician. The IME opinion lost persuasive force when weighed against sixteen months of documented clinical decisions.

Settlement and Lien Resolution

The UIM claim settled for a substantial portion of the $100,000 policy limit. Combined with the $15,000 already received from the at-fault carrier, Kevin's gross recovery was meaningful.

From the gross recovery, the attorney fee was deducted, along with case costs. The pharmacy lien was then submitted for resolution. Standard lien reduction negotiations produced a negotiated payoff that was paid from Kevin's net recovery. Kevin received his distribution after all liens were resolved.

His pain management physician documented at final evaluation that Kevin's L4-L5 herniation had not required surgery — an outcome she attributed in part to consistent medication management throughout the case. Kevin reported at follow-up that his ability to return to freelance work had increased steadily as his pain became more controlled, which had partially offset his income loss during the period of peak impairment.

The Pharmacy Lien as Coverage Bridge

This case demonstrates the specific value of pharmacy lien in the underinsured motorist context:

The at-fault limits are never enough. In states with low minimum liability requirements, the at-fault carrier will often exhaust quickly on any significant injury case. The gap between exhaustion and UIM resolution can span a year or more. The pharmacy lien covers that gap without asking the patient to self-fund.

UIM carriers investigate aggressively. Because the pharmacy lien record is objective and dated, it creates a treatment timeline that is difficult to dispute. The record does not rely on patient self-reporting — it reflects actual prescription fills, actual physician decisions, and actual medication changes over time.

No insurance coordination required. The pharmacy lien is entirely separate from the UIM claim process. Kevin's medications continued regardless of the state of the UIM investigation, and the lien was resolved only after the UIM settlement funds were in hand.

[!KEY] In UIM cases, the pharmacy lien effectively functions as a bridge loan on medication access — one that is repaid only when the settlement money actually arrives, with no interest charged to the patient in the interim.

Related Resources

• What Is a Pharmacy Lien?
• What Is a No-Fault State in Personal Injury?
• Herniated Disc Medications and Pharmacy Lien
• Pain Management Doctor and Pharmacy Lien Coordination
• Health Insurance Subrogation vs. Pharmacy Lien